Acumen Pharmaceuticals Inc
ABOS
$1.70+1.50%
Delayed · as of Oct 16, 2026, 2:45 PM ET
Mkt cap
$73.29M
EV/Sales
4.68
P/E ratio
N/A
FY2023 Revenue
$10.79M
EPS (H1 2026)
$-0.79
Gross Margin (FY2023)
N/A
Profit Margin (FY2023)
-485.32%
Beta
0.05
Div yield
N/A
Sector
Healthcare
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
Latest reported ABOS revenue for 2023-12-31 was $10.8M. Net income was -$52.4M. Revenue was up 351.1% from 2022-12-31 to 2023-12-31. ABOS currently screens at market cap $73.3M.
Use this ABOS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ABOS income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company in the Healthcare sector.
Latest cached Acumen Pharmaceuticals Inc (ABOS) revenue for Dec 31, 2023 was $10.8M. Net income was -$52.4M. Statements: https://lician.com/financials/abos
Acumen Pharmaceuticals Inc (ABOS) market capitalization is $73.3M on the latest cached snapshot.
Acumen Pharmaceuticals Inc (ABOS) cached previous close $1.67; day range $1.67 – $1.70; volume 282,281. Session quote: https://lician.com/quote/abos
Acumen Pharmaceuticals Inc (ABOS) latest cached earnings event is "ABOS earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABOS filing is 8-K · Sep 16, 2026. Filings: https://lician.com/sec/abos